Prescription drug coverage: an essential service or a fringe benefit?
作者信息
Tamblyn Robyn M
机构信息
Department of Medicine, McGill University, Montréal, Que.
出版信息
CMAJ. 2005 Nov 22;173(11):1343-4. doi: 10.1503/cmaj.051153.
Abstract
摘要
相似文献
1
Prescription drug coverage: an essential service or a fringe benefit?处方药保险：一项基本服务还是额外福利？
CMAJ. 2005 Nov 22;173(11):1343-4. doi: 10.1503/cmaj.051153.
2
Prescription drug prices in Canada.加拿大的处方药价格。
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)). 2003 Jun(IB62):1-22.
3
Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.评估台湾门诊处方药共付政策对老年人的影响。
Med Care. 2003 Dec;41(12):1331-42. doi: 10.1097/01.MLR.0000100579.91550.C4.
4
The prescription-drug problem.处方药问题。
N Engl J Med. 2002 Mar 14;346(11):790. doi: 10.1056/NEJM200203143461102.
5
The association of insurance type with costs of dispensed drugs.保险类型与配药费用的关联。
Inquiry. 1998 Spring;35(1):23-35.
6
Prescription-drug coverage for medicare beneficiaries.医疗保险受益人的处方药保险
N Engl J Med. 2003 Sep 4;349(10):923-5. doi: 10.1056/NEJMp038139.
7
Continuing policy issues in Medicare prescription drug coverage.医疗保险处方药覆盖范围中持续存在的政策问题。
Issue Brief (Commonw Fund). 2004 Nov(710):1-5.
8
Comparing prescription drug plans. New choices made available by Medicare Part D deserve serious study.比较处方药计划。医疗保险D部分提供的新选择值得认真研究。
J Am Vet Med Assoc. 2005 Dec 15;227(12):1884-5.
9
Medicare program; Medicare prescription drug benefit. Final rule.医疗保险计划；医疗保险处方药福利。最终规则。
Fed Regist. 2005 Jan 28;70(18):4193-585.
10
Medicare prescription drug coverage (part D): challenges and opportunities.
Nephrol News Issues. 2006 Aug;20(9):14-6, 18.
本文引用的文献
1
When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions.当患者需要承担部分药费时：对就诊频率、住院率和处方配药的影响。
CMAJ. 2005 Nov 22;173(11):1335-40. doi: 10.1503/cmaj.045146.
2
Intellectual property rights and the Canadian pharmaceutical marketplace: where do we go from here?知识产权与加拿大药品市场：我们将何去何从？
Int J Health Serv. 2005;35(2):237-56. doi: 10.2190/Y8UR-YWVR-BUDP-CDR0.
3
Canadian prescription drug costs surpass 18 billion dollars.加拿大的处方药费用超过180亿美元。
CMAJ. 2005 May 10;172(10):1323-4. doi: 10.1503/cmaj.050444.
4
Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence.处方药使用费对弱势群体药物及医疗服务使用和健康状况的影响：证据的系统评价
Int J Health Serv. 2004;34(1):101-22. doi: 10.2190/4M3E-L0YF-W1TD-EKG0.
5
The new Medicare prescription-drug benefit--a pure power play.新的联邦医疗保险处方药福利——纯粹是一场权力博弈。
N Engl J Med. 2004 Feb 19;350(8):826-33. doi: 10.1056/NEJMhpr045002.
6
Beneficiary cost sharing under Canadian provincial prescription drug benefit programs: history and assessment.加拿大省级处方药福利计划下的受益方费用分担：历史与评估
Can J Clin Pharmacol. 2002 Summer;9(2):79-99.
7
Pharmaceutical cost control in Canada: does it work?加拿大的药品成本控制：它有效吗？
Health Aff (Millwood). 2001 May-Jun;20(3):92-103. doi: 10.1377/hlthaff.20.3.92.
8
Medicare and prescription drugs.医疗保险与处方药。
N Engl J Med. 2001 Mar 29;344(13):1010-5. doi: 10.1056/NEJM200103293441311.
Zotero 插件